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Introduction
Maggot therapy is the application of sterile first in-
star larvae (maggots) fly larvae to debride the
chronic wound bed of necrotic tissue, reduce the
bacterial contamination and enhance the formation
of healthy granulation tissue. In human medicine
the use of maggot therapy has been practiced spo-
radically from centuries. Evidence suggests that an-
cient Mayans, as a means of attracting maggot
strikes, soaked dressings in cattle blood and applied
them to their own wounds (Sherman and Pechter,
1988). In 1559, Pare noted the beneficial effects of
maggots in combating trauma in the battlefield
(Trudgian, 2002). The first documented application
of maggots was by John Zacharias, a surgeon in the
American civil war as follows: “During my service
in the hospital at Danville, Virginia, I first used
maggots to remove the decayed tissue in hospital
gangrene and with eminent satisfaction. In a single
day, they would clean a wound much better than
any agents we had at our command. I used them af-
terwards at various places. I am sure I saved many
lives by their use, escaped septicaemia, and had
rapid recoveries” (Chernin, 1986).
Prior to the development of antibiotics, maggot
therapy was used particularly for the treatment of
various types of necrotic wounds including chronic
leg ulcers, osteomyelitis and greatly improved the
prognosis for patients with such conditions (Trud-
gian, 2002). William S. Baer, Professor of Or-
thopaedic Surgery at the John Hopkins School of
Medicine in Maryland, USA, is believed to be the
founder of modern maggot therapy. Baer was im-
pressed by the remarkable healing of compound
fractures of the femur and large abdominal wounds
in a soldier left unattended for several days without
food or water. Although his wounds were covered
with thousands of maggots, the patient was
afebrile, no bare bone was seen, and healthy gran-
ulation tissue surrounded the traumatized tissues.
Similarly open lesions in all the 21 patients at Johns
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Hopkins University in 1929 with chronic in-
tractable osteomyelitis healed completely without
any complications owing to application of maggots
by Baer (1931). Despite obvious success of maggot
therapy, by the mid-1940s it had practically disap-
peared from use due to introduction and wide-
spread use of various antibiotics. Innovative
surgeons and practitioners are now taking a second
look at maggots, especially with regard to the gear
up in antibiotic resistance. In addition to the idea
of antibiotic resistance, cases that might benefit
from maggot therapy are those where the blood
supply to a region is compromised or in the process
of regenerating; maggots can consume infected tis-
sue since there is no blood to bring antibiotics to
the area (Honnas et al., 1995).
With the increasing incidence of bacterial resist-
ance to antibiotics, the great expense and protracted
development of new antibiotics and the high cost
of prolonged treatment, interest in the use of mag-
got-therapy in human medicine is growing at a
faster rate. Maggot therapy, however, is used rela-
tively little in veterinary medicine. Nevertheless,
concern over antibiotic resistance and the increase
in demand for organic husbandry and residue-free
meat and milk, suggest that it is an option which
merits further consideration.
Types of fly larvae used in maggot therapy
The majority of the fly larvae associated with myi-
asis are not suitable for therapy. Species of the ob-
ligate agents of myiasis, such as the flesh fly
Wohlfahrtia magnifica (Diptera: Sarcophagidae)
and the screw worm species, Chrysomya bezziana
or Cochliomyia hominivorax (Diptera: Calliphori-
dae) are not used since these flies feed aggressively
on underlying living tissue (Jones and Wall, 2008).
The larvae of facultative agents of myasis, partic-
ularly Lucilia serrata (Diptera: Calliphoridae) – the
familiar greenbottle blowfly responsible for
blowfly strike of sheep, feed relatively superficially
and therefore are the most suitable and commonly
used species (Prete, 1997).
Mechanism of action
The beneficial effects of maggot therapy on in-
fected wound are mainly due to debridement, dis-
infection and enhanced healing. Debridement is the
removal of cellular debris and non-viable necrotic
tissue from the wound bed. This is a first, essential
step before healing can commence. How exactly
maggots remove devitalized, necrotic tissue from
the wound is currently actively being investigated.
Research into the debridement mechanisms under-
lying maggot therapy has revealed that maggots se-
crete a rich soup of digestive enzymes while
feeding, including carboxypeptidases A and B
(Vistnes and Ksander, 1981), leucine aminopepti-
dase, collagenase (Ziffren et al., 1953) and serine
proteases (trypsin-like and chymotrypsin-like en-
zymes) (Casu et al., 1994). Recently four prote-
olytic enzymes, secreted by P. sericata larvae,
comprising two serine proteases, a metalloprotease
and an aspartyl protease have been detected with
activity across a wide pH range. A chymotrypsin-
like serine protease exhibited excellent degradation
of extracellular matrix (ECM) components laminin,
fibronectin, and collagen types I and III (Chambers
et al., 2003), and may therefore play a significant
role in the digestion of wound matrix and effective
debridement. The mechanical action of numerous
wriggling maggots in a necrotic debris-filled
wound has also been suggested in aiding wound
debridement. Maggots possess a pair of mandibles
(hooks) which assist in locomotion and attachment
to the tissues. This probing and maceration of
wound tissue with maggot mouth hooks may en-
hance debridement, but these hooks are used during
feeding to disrupt membranes and thus facilitate the
penetration of proteolytic enzymes (Thomas et al.,
1996). Maggots are photophobic and will naturally
move into the deep crevices that may be beyond
the reach of a surgeon’s scalpel (Nigam et al.,
2006a). Removal of necrotic tissue abolishes many
of the associated bacteria and also reduces wound
odour. The removal of necrotic tissue, which acts
as a microbial substrate, may also reduce the risk
of infection (Schultz et al., 2003). This therapy is
suitable for most types of wounds that contain
necrotic or sloughed tissue irrespective of etiology.
Further several mechanisms have been described
which enhance the healing of infected wounds
which include, actual ingestion of the tissue by the
larvae, physical presence of the larvae in the in-
fected tissue increasing the exudate from the host
which washes out the bacteria, secretions from the
larvae altering the wound pH, digestion and subse-
quent destruction of bacteria in the larval alimen-
tary tract due to antibacterial substances and the
crawling action of the larvae stimulating granula-
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tion tissue (Weil et al., 1933, Mumcuoglu et al.,
1998, Bunkis et al., 1985).
Application of Maggots
Before application of maggots, it should be borne
in mind that maggot therapy is only useful to
chronic wound which contain necrotic and
sloughed tissues (Hobson, 1931). The different
types of wounds suitable for application of mag-
gots include infected wounds, wet necrotic /
sloughy wounds, leg ulcers, pressure sores, surgical
wounds, malignant wounds, diabetic foot ulcers,
amputation wounds and indolent wounds (Schultz
et al., 2003). Wounds not suitable for maggot ther-
apy include, dry necrotic wounds, fistulae, wounds
that connect with abdominal cavity or the other or-
gans, wounds that bleed easily and the wounds
close to major blood vessels (Mumcuoglu et al.,
1998).
Medical maggot therapy in the United States is
regulated by the Food and Drug Administration;
maggots are purchased by prescription through a
licensed laboratory (eg, Monarch Labs, monarch-
labs.com). At the laboratory, fly eggs are washed
with dilute disinfectant, packaged in sterile contain-
ers and allowed to hatch at room temperature. The
hatched instar-1 larvae (larvae in the first develop-
mental stage) are translucent white and approxi-
mately 2 mm long. Over 4 to 5 days they undergo
2 additional molts, reaching 10 to 14 mm long.
Maggots are shipped overnight in a temperature-
controlled package. Larvae are used within 24
hours of arrival; however, if necessary, they can be
refrigerated for up to 60 hours.
Before placing the maggots, the wound is filled
with sterile water-soluble jelly and a wide area
around the wound is clipped and vacuumed. The
wound bed is then lavaged with 0.9% saline to
flush any lubricant or residual topical wound
agents. This is especially important if products con-
taining propylene glycol have been used, since
these can have a negative effect on maggot viabil-
ity. The surrounding skin is then cleaned with an-
tiseptic soap, and the area is dried and swabbed
with isopropyl alcohol (not to be placed directly on
the wound) to remove all dirt and oils. Then a hy-
drocolloid sheet of the appropriate size is taken and
a hole is cut in it according to size and shape of the
wound and placed securely onto the surrounding
skin. This protects the peri-wound skin and forms
a layer upon which to attach the nylon net. Now
slowly the saline containing the maggots is poured
onto a piece of specially designed net which is in-
verted over the wound and taped securely to the hy-
drocolloid sheet using a waterproof adhesive tape
such a sleek. The maggots will not fall off the net
when it is inverted, as they will be held in place by
surface tension. The resultant assembly forms an
enclosure that prevents the maggots from escaping
onto the surrounding skin. The central part of the
net must remain unoccluded in order to permit free
drainage of exudate and allow the maggots to ob-
tain an adequate supply of oxygen. After 24 hours
of application, maggots are watered by removing
the outer dressing (leaving the net and maggots in-
tact) and fresh gauze moistened, but not saturated,
with saline is reapplied over the net (Thomas et al.,
1996). 
The maggots are usually left on a wound for 72
hours, because under ideal conditions they will be
fully grown by this time. Sometimes, however, if
their growth rate is reduced, it may be appropriate
to wait for an additional day. The net retention
dressing is removed with or without the hydrocol-
loid frame and maggots are detached with a gloved
hand or a pair of forceps. The wound can be gently
irrigated with sterile water or saline to remove any
remaining or missed maggots. If any maggots are
left in the wound, these can be retrieved at the next
dressing change. When all the maggots have been
removed, the wound should be reassessed to see if
further maggot therapy is required or whether a
change to this therapy is indicated (Jones and
Thomas, 2000).
Maggot therapy in Veterinary medicine
The use of maggots to clean dead tissue from ani-
mal wounds is part of folk medicine in many parts
of the world. It is particularly helpful with chronic
osteomyelitis, chronic ulcers, and other pus-pro-
ducing infections that are frequently caused by
chafing due to work equipment in animals used for
draught purpose. Maggot therapy for horses in the
United States was re-introduced after a study pub-
lished in 2003 by veterinarian Dr. Scott Morrison. 
In horses, maggot debridement therapy is described
as an alternative approach to the management of
septic navicular bursitis, hoof infections and necro-
sis in cases of complicated laminitis (Morrison,
2005), osteomyelitis and other hoof diseases (Jurga
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and Morrison, 2004). This therapy has also been
used in supraspinous bursitis, a pathology rarely
encountered in equids in the developed world
(Doumbia, 2006). When treating this type of
wound with maggots the practitioner creates or
uses existing openings at either ends of the necrotic
cavities to ensure free drainage of exudate and af-
ford the maggots an adequate supply of oxygen.
Zinc paste is placed along the margins of these
openings, to protect normal tissue, and they are left
open.  No occlusive or film dressings should be ap-
plied overtop, as these may cause the maggots to
suffocate. The nets with maggots are changed every
2 to 3 days until complete wound debridement and
pink granulation tissue is observed without evi-
dence of infection. 
Maggot therapy has been found to decrease the
healing time in post-surgical coffin bone debride-
ments, useful in treating chronic reoccurring non-
healing foot ulcers, canker, quittor (necrosis of
collateral cartilage), navicular bursa sepsis, chronic
osteomyelitis/septic arthritis, chronic soft tissue ab-
scess and osteomyelitis secondary to digital insta-
bility such as chronic laminitis and reverse rotation
secondary to ruptured deep digital flexor tendon
(Honnas et al., 1992). The other conditions in
horses which can be successfully treated by maggot
therapy include, chronic digital interphalangeal
joint sepsis, acute caudal coffin bone rotation and
non-healing foot ulcers (Wrights et al., 1999,
Richardson et al., 1986).
Severe, localised, suppurative panniculitis sec-
ondary to a skin wounds in donkeys has been suc-
cessfully treated by application of sterile larvae
(maggots). The lesion did not respond to conven-
tional medical and surgical treatment and continued
to progress (Bell and Thomas, 2001). Maggot ther-
apy is also being used in dogs, cats and rabbits to
ensure proper debridement and control infection,
especially if the wound fails to respond to conven-
tional medical and/or surgical therapy (Sherman et
al., 2007).
Kocisova et al (2006) used maggot therapy in
sheep with acute and chronic interdigital skin in-
flammation. Before using maggot therapy, they
were unsuccessfully treated by a footbath contain-
ing 10% copper sulphate and topical application of
oxytetracycline solution in alcohol. During the
therapy larval population used was that of 8-12 per
square centimetre of wound and all affected tissues
were trimmed away before the application. The ef-
fect of a single application for 3-6 days was evalu-
ated. Debridement was rapid and selective and
treatment was well tolerated by animals. It was ob-
served that maggots of L. sericata were capable of
cleaning the wounds after single application. Vet-
erinarians at Oklahoma State University Veterinary
Hospital successfully used maggots to clear away
dead flesh from a wound of a 16 month old filly
horse that had been bitten by a rattlesnake. The 16-
month-old filly was bitten on the head by a rat-
tlesnake, causing its neck to swell to five times its
normal size (http://www.thehorse.com/ViewArti-
cle.aspx?ID=8113). 
From these observations in veterinary medicine
and different evidences in human medicine (Nigam
et al., 2006b), maggot therapy can be recom-
mended for wound debridement, disinfection, en-
hanced healing and a potent antibacterial action. 
Maggot therapy is now well established in mod-
ern wound care, with larvae provided by dedicated
fly culture laboratories in North America, Europe
and Israel (Ryan, 1997). The expectation is that
there will be a steady increase in demand for this
therapy, particularly as its efficacy and cost effec-
tiveness become more widely recognized. There re-
mains, however, understandable caution and
scepticism among clinicians, which can only be
overcome by the positive findings of prospective
clinical trials, which demand multi-centre collabo-
ration, funding and time. There is an overwhelming
need for improved wound care in countries which
are under-provided for medical veterinary facilities,
mostly in the tropics; the hope is that once the ad-
vantages of maggot therapy is fully perceived in
the developed world, low-cost local fly culture lab-
oratories will be established in regional centres in
the tropics.
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